[1] |
ZHANG Zhiyue, HE Huijing, SHAN Guangliang, LIN Yansong.
Research progress in epidemiology and risk factors of thyroid cancer
[J]. China Oncology, 2025, 35(1): 21-29.
|
[2] |
WANG Zhiting, REN Min, XUE Tian, WANG Haochen, CHANG Heng, BAI Qianming, ZHOU Xiaoyan, ZHU Xiaoli.
Comparison of fluorescence in situ hybridization (FISH) and urine cytology in diagnosing urothelial carcinoma: a single-center retrospective cohort study
[J]. China Oncology, 2024, 34(12): 1080-1089.
|
[3] |
TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong.
Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
[J]. China Oncology, 2023, 33(5): 478-483.
|
[4] |
CAO Mengxuan, HU Can, ZHANG Yanqiang, HUANG Ling, DU Yian, YU Pengcheng, ZHANG Ruolan, XU Zhiyuan, CHENG Xiangdong.
Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer
[J]. China Oncology, 2022, 32(7): 588-595.
|
[5] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[6] |
DING Pingan, YANG Peigang, TIAN Yuan, GUO Ziyang, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun.
Effect of extranodal invasion on survival and prognosis of gastric cancer patients: a report of 2 386 cases
[J]. China Oncology, 2020, 30(12): 1017-1025.
|
[7] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[8] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[9] |
LIU Xiaoxue, YU Chuanhua, ZHOU Wei, et al.
Trends in colorectal cancer mortality for the last 30 years in China
[J]. China Oncology, 2018, 28(3): 177-183.
|
[10] |
LIN Xuedan, YANG Tianxing,TAO Zhihua.
Predictive value of CEA and CA19-9 for recurrence in stage Ⅱ-Ⅲ colon cancer
[J]. China Oncology, 2018, 28(11): 827-832.
|
[11] |
NIE Jun, ZHOU Bo, ZHANG Yulin.
The expression and clinical significance of PANDAR in non-small cell lung cancer
[J]. China Oncology, 2017, 27(7): 569-574.
|
[12] |
SHEN Lihua, ZHANG Zhongwei, ZHU Biao.
Clinical analysis of tumor related venous thromboembolism: 196 cases
[J]. China Oncology, 2016, 26(4): 338-345.
|
[13] |
DONG Fen, ZHANG Biao, SHAN Guangliang.
Distribution and risk factors of thyroid cancer in China
[J]. China Oncology, 2016, 26(1): 47-52.
|
[14] |
LI Yuanyuan, WANG Hongyan, WU Xiaoyan, et al.
Effects of progranulin on proliferation and senescence in gastric cancer cells
[J]. China Oncology, 2015, 25(3): 173-178.
|
[15] |
HUA Yong-qiang,CHEN Hao,MENG Zhi-qiang,CHEN Zhen,LIN Jun-hua,LIU Lu-min,ZHU Xiao-yan,SHEN Ye-hua,WANG Peng,GAO Hui-feng,XIE Jing.
Risk factors for 302 hepatic malignancies cases with residual tumor after ultrasound-guided radiofrequency ablation treatment
[J]. China Oncology, 2014, 24(2): 119-127.
|